FDA approves Benlysta for treatment of children with systemic lupus erythematosus (SLE), a chronic disease causing inflammation and damage to tissue and organs
Original source: http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-pediatric-patients-lupus
